A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products

Inclusion Criteria:

1. Have provided informed consent, as required per local regulations 2.a) Adultpatient, as defined by local regulations and local product label, who is newlyinitiating treatment (or initiated treatment in the previous visit) with a specifiedapproved Roche ophthalmology product in retinal indication of interest for thisstudy in at least one eye, according to the investigator's discretion in routineclinical practice; OR 2.b) Adult patient, as defined by local regulations and localproduct label, who is continuing treatment with any specified approved Rocheophthalmology product in retinal indication of interest for this study in at leastone eye after initiating that treatment in a Roche interventional trial.

Exclusion Criteria:

1. Concomitant participation of the patient in an investigational ophthalmologyclinical trial that includes receipt of any investigational drug or procedure withinthe last 28 days prior to enrollment (this restriction does not apply to patientswho are rolling over from Roche interventional studies and continuing treatment withany specified approved Roche ophthalmology product in retinal indication of interestfor this study)